Quark Pharmaceuticals quarkpharma.com


Public list: Pharma Startups (4743) Eye Health (701)

Fremont, California, July 30, 2008 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing RNA interference (RNAi)-based therapeutics, today announced that its partner, Pfizer Inc, initiated patient dosing in a Phase II trial evaluating PF-4523655 (RTP801i-14) in patients with diabetic macular edema (DME). PF-4523655 is a siRNA drug candidate being co-developed by Quark and Pfizer. As part of the companiesĀf Global Licensing Agreement, the successful c...Show all

Fremont, California, July 30, 2008 Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing RNA interference (RNAi)-based therapeutics, today announced that its partner, Pfizer Inc, initiated patient dosing i...Show all

Company (Alive / Active)

Phone: 510-402-4020

Fax:

6501 Dumbarton Circle

Fremont, 94555
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Quark Pharmaceuticals $37M Jun 10, 2010
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Quark Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Mitsubishi UFJ CapitalCorporate VentureTokyo, JapanOther Investors
SBI InvestmentCorporate VentureTokyo, JapanSeries F, Series E
See all 2 investors

Board Members

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Double-stranded oligonucleotide molecules to p53 and methods of use thereof Sep 12, 2013 Apr 03, 2018 Patent
Methods and compositions for preventing ischemia reperfusion injury in organs Jul 14, 2017 Jan 16, 2018 Patent
Compositions and methods for treating lung disease and injury Oct 28, 2015 Nov 21, 2017 Patent
Oligonucleotide modulators of the toll-like receptor pathway Jul 28, 2016 Oct 24, 2017 Patent
Methods and compositions for neuroprotection Aug 04, 2016 Aug 22, 2017 Patent
See all 73 patents